Logo UE
Copolad
Cooperation Program between
Latin America, the Caribbean and the European Union
on drug policy
No Result
View All Result
Copolad II 2015-2020
  • COPOLAD
    • What is COPOLAD?
    • Context
    • How we work
    • Objectives
    • Participants/Allies
    • Technical team
    • Public Tenders
  • Work Areas
    • National Drug Observatories
    • Demand Reduction
    • Fight against drug trafficking
    • Alternative Development
    • Control of drug precursor chemicals
    • Proportionality and criminal alternatives
    • EU-CELAC dialogue on drug policies
    • Women and Drugs
    • Policy innovation
  • Program Results
  • Knowledge Portal
    • COPOLAD III Meetings
    • Directory of centers and services
    • Library
    • Blog
    • Work groups
  • Comunication
    • News
    • Albums
    • Videos
    • Press releases
    • COPOLAD in media
  • English
    • Español
  • COPOLAD
    • What is COPOLAD?
    • Context
    • How we work
    • Objectives
    • Participants/Allies
    • Technical team
    • Public Tenders
  • Work Areas
    • National Drug Observatories
    • Demand Reduction
    • Fight against drug trafficking
    • Alternative Development
    • Control of drug precursor chemicals
    • Proportionality and criminal alternatives
    • EU-CELAC dialogue on drug policies
    • Women and Drugs
    • Policy innovation
  • Program Results
  • Knowledge Portal
    • COPOLAD III Meetings
    • Directory of centers and services
    • Library
    • Blog
    • Work groups
  • Comunication
    • News
    • Albums
    • Videos
    • Press releases
    • COPOLAD in media
  • English
    • Español
No Result
View All Result
Copolad
No Result
View All Result
Home News

Uruguay promotes the first social innovation lab to tackle drug micro-trafficking

Uruguay launches, with the support of COPOLAD III, a social innovation laboratory that seeks to provide alternatives for women in vulnerable conditions, who find in drug micro-trafficking an economic livelihood to cover their family needs

12/11/2024
in News
Uruguay impulsa el primer laboratorio de innovación social para abordar el microtráfico de drogas

Uruguay impulsa el primer laboratorio de innovación social para abordar el microtráfico de drogas

Compartir en FacebookCompartir en TwitterCompartir en Linkedin

COPOLAD III, the National Drug Board of Uruguay and Agirre Lehendakaria Center, a social innovation laboratory linked to the University of the Basque Country, have combined their knowledge and experience to set up a social innovation laboratory in the metropolitan region of Montevideo, dedicated to promoting innovative strategies to prevent drug micro-trafficking. This laboratory will work with a focus on women in charge of minors who, on occasions, form part of the illicit drug trafficking chain as they find in this business an economic livelihood strategy. ‘Laboratories’ because they are spaces for experimentation, ‘innovation’ because they seek to provide different answers through shared learning and ‘social’ because they do so with proposals that come from the communities themselves.

As part of this initiative, the first sessions of this laboratory took place between 6 and 8 November. Representatives from the National Drug Board, the NGO El Abrojo, the National Directorate for the Support of the Released (DINALI) and the National Women’s Institute (Inmujeres) participated in the sessions.

In addition, the team participated in a community meeting in El Achique, a day centre for care, treatment and coexistence for people in situations of socio-economic vulnerability and/or problematic substance use. On this day, a first session of interpretation and collective listening was held to share the different ways of perceiving the same problem and that, repeated over time, can help to generate shared visions and a deeper analysis of the critical nodes on which to focus public policy strategies in terms of social innovation.

This analysis will inform the process of co-designing solutions that will take place over the coming months. The aim is to ensure that the strategies developed by the teams incorporate the capacity to respond to the different narratives and perceptions that exist in the territory and allow them to constantly adapt to changes, thus generating flexible governance systems to address complex challenges such as drug micro-trafficking.

COPOLAD III and the Agirre Lehendakaria Center are already developing 3 other social innovation laboratories in Chile to address drug use among minors under the guardianship and protection of the State, in Colombia to address the drug problem from a social inclusion approach and within the framework of Colombia’s National Drug Policy, focusing on vulnerable youth, and in Peru to promote an Early Warning System (EWS) to protect native communities from illicit drug cultivation businesses.

Tags: innovationlaboratorieslaboratorylabsuruguay

Últimas noticias

Guide for line 171 (option 6)

Life is our answer

Legal pages

  • Legal notice

  • Privacy police

  • Cookies policy

  • Accesibility

Social media

COPOLAD is a consortium formed by:

4.-Version-negativa-color-con-tagline-1024x375
logo iila

Collaborating partners:

logo giz
No Result
View All Result
  • COPOLAD
    • What is COPOLAD?
    • Context
    • How we work
    • Objectives
    • Participants/Allies
    • Technical team
    • Public Tenders
  • Work Areas
    • National Drug Observatories
    • Demand Reduction
    • Fight against drug trafficking
    • Alternative Development
    • Control of drug precursor chemicals
    • Proportionality and criminal alternatives
    • EU-CELAC dialogue on drug policies
    • Women and Drugs
    • Policy innovation
  • Program Results
  • Knowledge Portal
    • COPOLAD III Meetings
    • Directory of centers and services
    • Library
    • Blog
    • Work groups
  • Comunication
    • News
    • Albums
    • Videos
    • Press releases
    • COPOLAD in media
  • English
    • Español
Copolad II 2015-2020

© COPOLAD. Programa de Cooperación entre América Latina, el Caribe y la Unión Europea en Políticas sobre Drogas.